Manuscripts submitted to Latin American Journal of Pharmacy are only accepted on the understanding that they are subject to editorial review and that they have not been, and will not be, published in whole or in part in any other journal.

Papers must be written in English. If English is not authors' native language, the manuscript should be checked by someone proficient in the language before submission. Manuscripts in which English is difficult to understand may be returned to the author for revision before scientific review.




Types of Contribution

Original articles should contain material that has not been previously published elsewhere, except in a preliminary form. These papers should not exceed 5000 words. Short Communications are research papers constituting a concise but complete description of a limited investigation, which will not be included in a later paper. They should be as completely documented as a regular paper and should not occupy more than 2,500 words. Reviews and mini-reviews will be exceptionally accepted in areas of topical interest and will normally emphasize literature published over the previous five years. Letters to the Editor are published from time to time on subjects of topical interest.




Manuscript Preparation

Manuscripts must be neatly typed (size page A4), double-spaced throughout, including tables, with at least 2 cm margins on all sides. The Editor reserves the right to adjust style to certain standards of uniformity. Every page of the manuscript must be numbered at the right top, preceded by the name of the author to whom the correspondence should be sent. The usage of italics should be limited to scientific names of organisms. A cover letter is not required, but if included it should be placed at the beginning of the manuscript.

Manuscripts in general should be organized in the following order:

• Title: should be clear, concise, and unambiguously reflect the paper's contents.

• Name(s) of author(s): first name, initial(s) of the middle name(s), and family name of each author. The corresponding author should be identified with an asterisk (*).

• Affiliations: include the name of department (if any), institution, city and state or country where the work was done, indicating which authors are associated with which affiliation.

• E-mail address of the corresponding author, as all correspondence, including proofs, should be sent only to him.

• Summary: not exceeding 150 words, reporting concisely on the major findings. Many abstracting services use abstracts without modification, so this section should be comprehensible in its own right.

• Key Words: at least three and not more than six in alphabetical order will be listed.

• Introduction: briefly review important prior publications and state the reasons for the investigation being reported.

• Materials and methods: description of methods, equipment and techniques (including statistical treatments used in the research).

• Results: efforts should be made to avoid jargon, to spell out all non-standard abbreviations the first time they are mentioned and to present the contents of the study as clearly and concisely as possible.

• Discussion (may be combined with the Results section).

• Conclusions (at the author's discretion): must not reiterate any discussion or introductory comments, they must be genuine conclusions drawn from the results of the study.

• Acknowledgements and any additional information concerning research grants, etc.

• References: will be numerated correlatively as they are cited in the text and listed separately under the title References (please use a hanging indent: second and subsequent lines indented). The style used for citation of articles in journals (1), monographs (2), and chapters in books (3), which must be strictly observed, is given in the following examples:

	(1)	Medeiros R., G.F. Passos, C.E. Vitor J. Koepp, T.L. Mazzuco, L.F. Pianowski, M.M . Campos & J.B. Calixto (2007) Brit. J. Pharmacol. 151: 618–27. Journal names should be abbreviated according to ISI style (you are invited to consult the site http://www.efm.leeds.ac.uk/~mark/ISIabbr/A_abrvjt.html)
	(2)	Vogel, W.H., B.A. Scholkens, J. Sandow & G. Muller (2002). "Drug discovery and evaluation, Pharmacological assay", Second Edition, Spinger-Verlag, Berlin Heidelberg, New York, pp. 906-44.
	(3)	Aristide, V. & J.W. Martin (2005) "Doxorubicin", in "Analytical profiles of drug substances" (F. Klaus, ed.), Academic Press, New York, pp. 245-74.

• Tables and Figures: will be numbered using Arabic numerals in the order they appear in the text. Letters and symbols included into the figures should be made in a suitable size, since figures are usually reduced to half a column wide size (7.5 cm). Photographs, charts and diagrams are all to be referred to as "Figures". They should accompany the manuscript. All illustrations should be clearly marked with the figure number. All figures are to have a self-explanatory caption. Captions of Tables and Figures should be supplied on a separate sheet.